| Original language | English (US) |
|---|---|
| Pages (from-to) | 1012-1013 |
| Number of pages | 2 |
| Journal | Hepatology |
| Volume | 75 |
| Issue number | 4 |
| DOIs |
|
| State | Published - Apr 2022 |
ASJC Scopus subject areas
- Hepatology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Primary biliary cholangitis : 2021 practice guidance update from the American Association for the Study of Liver Diseases. / Lindor, Keith D.; Bowlus, Christopher L.; Boyer, James et al.
In: Hepatology, Vol. 75, No. 4, 04.2022, p. 1012-1013.Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Primary biliary cholangitis
T2 - 2021 practice guidance update from the American Association for the Study of Liver Diseases
AU - Lindor, Keith D.
AU - Bowlus, Christopher L.
AU - Boyer, James
AU - Levy, Cynthia
AU - Mayo, Marlyn
N1 - Funding Information: The funding for the development of this practice guidance was provided by the American Association for the Study of Liver Diseases. This updated practice guidance was approved by the American Association for the Study of Liver Diseases on July 30, 2021. The authors are grateful for the valuable contributions of the American Association for the Study of Liver Diseases Practice Guideline Committee. Members of the committee include George Ioannou (chair); Rabab Ali, Scott W. Biggins, Roniel Cabrera, Henry Chang, Michael F. Chang, Albert Do, David S. Goldberg, R. W. Ray Kim (board liaison), Lindsay Y. King, Cynthia Levy, Jeff McIntyre, Jessica L. Mellinger, Anthony J. Michaels, Mindie H. Nguyen, Nadia Ovchinsky, Anjana A. Pillai, Daniel S. Pratt, Hugo R. Rosen, Christopher J. Sonnenday, Matthew J. Stotts, Lisa B. VanWagner, and Elizabeth C. Verna. Funding Information: Dr. Mayo consults for and received grants from Cymabay. She received grants from Intercept. Dr. Levy consults for, advises, and received grants from Intercept, Cymabay, Genfit, GSK, Pliant, Mirum, and Cara Therapeutics. She consults for and advises Escient, Teva, and Calliditas. She received grants from Gilead, Novartis, High Tide, Zydus, and Target PharmaSolutions. She receives royalities from Up‐to‐date.
PY - 2022/4
Y1 - 2022/4
UR - http://www.scopus.com/inward/record.url?scp=85121426341&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121426341&partnerID=8YFLogxK
U2 - 10.1002/hep.32117
DO - 10.1002/hep.32117
M3 - Comment/debate
C2 - 34431119
AN - SCOPUS:85121426341
SN - 0270-9139
VL - 75
SP - 1012
EP - 1013
JO - Hepatology
JF - Hepatology
IS - 4
ER -